Publication:
Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure.

Simple item page
dc.contributor.authorPerez-Belmonte, Luis M
dc.contributor.authorMiramontes-Gonzalez, Jose P
dc.contributor.authorOsuna-Sanchez, Julio
dc.contributor.authorLara, Jose P
dc.contributor.authorGómez-Huelgas, Ricardo
dc.date.accessioned2023-05-03T13:29:16Z
dc.date.available2023-05-03T13:29:16Z
dc.date.issued2022-01-29
dc.description.abstractWe greatly appreciate the comments from Ismayilovet al. 1 regarding our recent publication on the clinicalbenefits of empagliflozin in very old patients in the hospi-tal setting.
dc.description.versionNo
dc.identifier.citationPérez-Belmonte LM, Miramontes-González JP, Osuna-Sánchez J, Lara JP, Gómez-Huelgas R. Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure. J Am Geriatr Soc. 2022;70:1585-1589
dc.identifier.doi10.1111/jgs.17703
dc.identifier.essn1532-5415
dc.identifier.pmid35174486
dc.identifier.urihttp://hdl.handle.net/10668/19985
dc.issue.number5
dc.journal.titleJournal of the American Geriatrics Society
dc.journal.titleabbreviationJ Am Geriatr Soc
dc.language.isoen
dc.organizationÁrea de Gestión Sanitaria Este de Málaga-Axarquía
dc.organizationHospital Universitario Regional de Málaga
dc.organizationHospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.organizationAGS - Este de Málaga-Axarquía
dc.page.number5
dc.provenanceRealizada la curación de contenido 26/09/2024
dc.publisherAmerican Geriatrics Society
dc.pubmedtypeLetter
dc.pubmedtypeComment
dc.relation.publisherversionhttps://doi.org/10.1111/jgs.17703
dc.subjectBenzhydryl Compounds
dc.subjectDiabetes Mellitus, Type 2
dc.subjectGlucosides
dc.subjectHeart Failure
dc.subject.decsBenzhydryl Compounds
dc.subject.decsDiabetes Mellitus, Type 2
dc.subject.decsGlucosides
dc.subject.decsHeart Failure
dc.subject.decsHumans
dc.subject.meshBenzhydryl Compounds
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshGlucosides
dc.subject.meshHeart Failure
dc.subject.meshHumans
dc.titleReply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure.
dc.typeletter to the editor
dc.volume.number70
dspace.entity.typePublication

Files

Collections

Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
SAS - Hospital Regional Universitario de Málaga

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía